1. Home
  2. OSS vs SGMT Comparison

OSS vs SGMT Comparison

Compare OSS & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo One Stop Systems Inc.

OSS

One Stop Systems Inc.

HOLD

Current Price

$8.39

Market Cap

197.3M

Sector

Technology

ML Signal

HOLD

Logo Sagimet Biosciences Inc. Series A

SGMT

Sagimet Biosciences Inc. Series A

HOLD

Current Price

$5.74

Market Cap

164.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSS
SGMT
Founded
1998
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
197.3M
164.6M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
OSS
SGMT
Price
$8.39
$5.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
$8.50
$27.00
AVG Volume (30 Days)
1.5M
566.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.49
EPS
N/A
N/A
Revenue
$37,027,382.00
$2,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
34.46
N/A
52 Week Low
$1.85
$1.73
52 Week High
$12.75
$11.41

Technical Indicators

Market Signals
Indicator
OSS
SGMT
Relative Strength Index (RSI) 45.80 51.03
Support Level $7.96 $5.60
Resistance Level $10.74 $6.72
Average True Range (ATR) 0.82 0.33
MACD -0.12 0.06
Stochastic Oscillator 20.18 62.78

Price Performance

Historical Comparison
OSS
SGMT

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bressner segment.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

Share on Social Networks: